ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
36 announcements with these filters
Fermenta Biotech granted 3,95,400 stock options to employees under its 2025 ESOP scheme. The move aims to incentivize personnel while the company seeks direct listing on NSE.
Fermenta Biotech Ltd reported revenue from operations of ₹121.6 Cr (-13.0% YoY) and net profit of ₹18.6 Cr (-44.1% YoY) for Q4 FY26.
Fermenta Biotech reported audited financial results for FY2026 and recommended a 75% final dividend. The board fixed August 5, 2026, as the record date for payment.
Fermenta Biotech scheduled a board meeting for May 26, 2026. Directors will consider FY26 audited financial results and a final dividend recommendation.
Fermenta Biotech Limited (BSE: 506414) confirmed it does not meet the criteria for a 'Large Corporate' entity for FY 2025-26. The company reported outstanding borrowings of ₹17.39 Crore as of March 31, 2026, which is below the regulatory threshold for mandatory debt market sourcing.
Fermenta Biotech Limited (506414) shares have been admitted to dealings on the National Stock Exchange (NSE) under the 'Permitted to Trade' category. Trading is effective from April 20, 2026, following NSE circular 0645/2026. This move enhances the stock's liquidity by providing an additional trading platform for investors.